Promise Ledger
Every outstanding corporate promise with a resolution deadline — and the ones that just resolved. Descriptive, sourced, receipt-backed.
Guidance withheld · 47
A company that guided consistently, then went silent — a fact, not a forecast.- BAXWithheld quarterly guidance for Q1 2026 after 20 consecutive guided quartersJun 30, 2026
- EQRWithheld quarterly guidance for Q1 2026 after 7 consecutive guided quartersJun 30, 2026
- DASHWithheld quarterly guidance for Q1 2026 after 11 consecutive guided quartersJun 30, 2026
- TXNWithheld quarterly guidance for Q1 2026 after 6 consecutive guided quartersJun 30, 2026
- IEXWithheld quarterly guidance for Q4 2025 after 15 consecutive guided quartersMar 31, 2026
- DALWithheld quarterly guidance for Q4 2025 after 16 consecutive guided quartersMar 31, 2026
- PTCWithheld quarterly guidance for Q3 2025 after 7 consecutive guided quartersDec 30, 2025
- FTVWithheld quarterly guidance for Q3 2025 after 18 consecutive guided quartersDec 30, 2025
Dividend activity · 300
Declared dividends, shown as history — descriptive, not scored, no verdict.43 resolved · Buyback · KEPT
- NUEBuybackNucor had approximately $2.32 billion remaining authorized and available for repurchases under its share repurchase programAug 12, 2026KEPT
- CAHBuybackBaseline share repurchases $500MAug 11, 2026KEPT
- VSTBuybackVistra expects to spend at least $2.25 billion on share repurchases throughout 2024 and 2025Aug 10, 2026KEPT
- ITWBuybackthe company plans to repurchase approximately $1.5 billion of its own sharesAug 6, 2026KEPT
- CFBuybackManagement intends to complete $3 billion share repurchase authorization by December 2025Aug 6, 2026KEPT
- MTCHBuyback$800 million remaining in our share buyback authorizationAug 5, 2026KEPT
- BALLBuybackexpand share repurchases to in the range of $1.3 billion by year endAug 4, 2026KEPT
- BKBuybackBoard of Directors authorized a new common share repurchase program of $6 billionJul 31, 2026KEPT
- AAPLBuybackThe board of directors has also authorized an additional program to repurchase up to $110 billion of the Company’s common stock.Jul 31, 2026KEPT
- ADBEBuybackwe are announcing a new $25 billion share repurchase programJun 15, 2026KEPT
- ULTABuybackapproved a new share repurchase authorization of $2.0 billionJun 2, 2026KEPT
- CSCOBuybackThe remaining authorized amount for stock repurchases under the program is $8.4 billionMay 19, 2026KEPT
- CPAYBuybackthe Company expects to enter into a 10b5-1 plan, which supports the Company's plan to repurchase up to $800 million of shares during 2024May 8, 2026KEPT
- FISBuybackat least $4.0 billionMay 8, 2026KEPT
- VSTBuybackBoard authorized an additional $1.5 billion of share repurchasesMay 8, 2026KEPT
- CFBuyback$3 billion share repurchase authorizationMay 7, 2026KEPT
- ITWBuybackthe company plans to repurchase approximately $1.5 billion of its own sharesMay 7, 2026KEPT
- GWWBuybackShare Buyback $0.9 - $1.1 billionMay 7, 2026KEPT
- DISBuybackwe plan to target $3 billion in repurchases in fiscal 2024.May 6, 2026KEPT
- BALLBuybackapproximately $2 billion of proceeds will be used to increase return of value to shareholders via share buybacksMay 5, 2026KEPT
- BLDRBuybackthe Company’s Board of Directors authorized the repurchase of up to $1.0 billion of the Company’s outstanding shares of common stockApr 30, 2026KEPT
- HCABuybackThe HCA Healthcare, Inc. Board of Directors has authorized an additional share repurchase program for up to $6 billion of the Company’s outstanding common stock.Apr 29, 2026KEPT
- PFGBuybackThe Board of Directors approved a new authorization for the repurchase of $1.5 billion of the company’s outstanding common stock.Apr 29, 2026KEPT
- LVSBuybackThe remaining amount authorized under our share repurchase program is $1.50 billion.Apr 24, 2026KEPT
- PHMBuybackbringing its total share repurchase authorization to $1.8 billionApr 23, 2026KEPT